RA Capital Management

Founded in 2004, RA Capital Management, L.P. (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, diagnostics, services, and research tools. It's strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, as well as to form new companies, seeking both to facilitate the multistage process and to allow management teams to strive to drive value creation with fewer capital concerns from inception through commercialization. At RA Capital’s core is its TechAtlas research division, a scientifically trained team that maps out competitive landscapes in a continual effort to put data into context, identify breakthroughs, and originate conviction in new ideas. TechAtlas provides RA Capital’s Investment Team and portfolio companies with strategic intelligence, market research, and other resources. The TechAtlas Team’s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.